SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235 | +147.4% | 67,754 | +229.1% | 0.02% | +122.2% |
| Q1 2023 | $95 | -73.3% | 20,588 | -53.2% | 0.01% | -79.5% |
| Q4 2022 | $356 | -100.0% | 44,032 | -73.4% | 0.04% | -63.9% |
| Q3 2022 | $919,000 | -19.1% | 165,544 | -24.1% | 0.12% | -28.2% |
| Q2 2022 | $1,136,000 | +290.4% | 218,115 | +515.4% | 0.17% | +335.9% |
| Q1 2022 | $291,000 | -72.6% | 35,442 | -50.4% | 0.04% | -70.9% |
| Q4 2021 | $1,063,000 | – | 71,412 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |